| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.38 | 0.01 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.02 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |